Aldehyde dehydrogenase involvement in a variant of the brown Norway rat acute myelocytic leukaemia (BNML) that acquired cyclophosphamide resistance in vivo
- 31 December 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (14) , 2137-2143
- https://doi.org/10.1016/0959-8049(94)00441-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Development and characterisation of a cyclophosphamide resistant variant of the BNML rat model for acute myelocytic leukaemiaEuropean Journal of Cancer and Clinical Oncology, 1991
- Molecular mechanisms of drug resistanceBiochemical Journal, 1990
- Development and characterization of a cyclophosphamide-resistant subline of acute myeloid leukemia in the Lewis x Brown Norway hybrid ratBlood, 1990
- Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in VivoScience, 1990
- Minimal residual disease in leukemia: Studies in an animal model for acute myelocytic leukemia (bnml)The International Journal of Cell Cloning, 1990
- Mechanisms of drug resistance in acute leukaemiaLeukemia Research, 1989
- Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-HydroperoxycyclophosphamideNew England Journal of Medicine, 1986
- A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitroCancer Chemotherapy and Pharmacology, 1986
- Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cellsBiochemical Pharmacology, 1984
- The problem of specificity and selectivity of alkylating cytostatics; studies on N-2-chloroethylamido-oxazaphosphorinesZeitschrift für Krebsforschung und Klinische Onkologie, 1977